Literature DB >> 14534882

Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.

Marcela G Del Carmen1, Anne E Smith Sehdev, Amanda Nickles Fader, Marianna L Zahurak, Michael Richardson, John P Fruehauf, F J Montz, Robert E Bristow.   

Abstract

BACKGROUND: Multiple epidemiologic and histologic studies have suggested that ovarian endometriosis can give rise to malignant ovarian tumors, primarily those of epithelial origin. The progression of endometriosis to endometriosis-associated ovarian carcinoma (EAOC) has not been investigated thoroughly and is poorly understood at best. Using immunohistochemical methods, we compared the differential expression patterns of various cytokines and growth factors in atypical endometriosis (AE) and EAOC.
METHODS: Using the Johns Hopkins Pathology Data Bank, tissue blocks from patients diagnosed with EAOC or AE were identified. Tissue blocks were stained for 4 markers: vascular endothelial growth factor (VEGF), Ki-67, estrogen receptor (ER), and progesterone receptor (PR).
RESULTS: Seventeen cases of EAOC and 8 cases of AE were identified. Staining for VEGF was documented in 16 of 17 (94%) EAOC tissue blocks and in only 1 of 8 (12.5%) AE tissue blocks (P < 0.0001). Only 4 of the 17 (23%) EAOC tissue blocks exhibited positive staining for ER, compared with 8 of 8 (100%) AE tissue blocks (P = 0.0005). Positive staining for PR was noted in only 6 of 17 (35%) EAOC samples but was present in 8 of 8 (100%) AE samples (P = 0.003). Seventy percent of EAOC samples exhibited positive staining for Ki-67, compared with 37.5% of AE samples (P = 0.19).
CONCLUSIONS: EAOC appears to be associated with overexpression of VEGF and reduced expression of both ER and PR. Variations in VEGF expression may be associated with the malignant transformation of endometriosis and may present both diagnostic and therapeutic options for the treatment of ovarian malignancies. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534882     DOI: 10.1002/cncr.11714

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.

Authors:  Xiaoying Tian; Limian Xu; Peng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model.

Authors:  Aaron K Styer; Brian T Sullivan; Mark Puder; Danielle Arsenault; John C Petrozza; Takehiro Serikawa; Sung Chang; Tayyaba Hasan; Ruben R Gonzalez; Bo R Rueda
Journal:  Endocrinology       Date:  2007-10-25       Impact factor: 4.736

Review 3.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

4.  Evaluation of the Pathogenesis of Tumor Development from Endometriosis by Estrogen Receptor, P53 and Bcl-2 Immunohistochemical Staining

Authors:  Esmaili Haidarali; Amir Vahedi; Shiva Mohajeri; Elmira Mostafidi; Mahzad Azimpouran; Mohammad Naghavi Behzad
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

Review 5.  Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis.

Authors:  Jiaxing He; Weiqin Chang; Chunyang Feng; Manhua Cui; Tianmin Xu
Journal:  Int J Genomics       Date:  2018-03-27       Impact factor: 2.326

6.  Endometrioid Carcinoma Arising from an Endometriosis-Associated Abdominal Wall Scar.

Authors:  Eduardo Paulino; Andreia Cristina de Melo; Vinicius Freire da Silva
Journal:  Am J Case Rep       Date:  2020-06-01

7.  Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study.

Authors:  Jin Young Jeong; Sung Ook Hwang; Banghyun Lee; Kidong Kim; Yong Beom Kim; Sung Hye Park; Hwa Yeon Choi
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

8.  Association between atypical endometriosis and ovarian malignancies in the real world.

Authors:  Kyeong A So; Sung Ran Hong; Nae Ri Kim; Eun Jung Yang; Seung-Hyuk Shim; Sun Joo Lee; Tae Jin Kim
Journal:  J Ovarian Res       Date:  2021-08-28       Impact factor: 4.234

Review 9.  A Systematic Review of Atypical Endometriosis-Associated Biomarkers.

Authors:  Ludovica Bartiromo; Matteo Schimberni; Roberta Villanacci; Giorgia Mangili; Stefano Ferrari; Jessica Ottolina; Noemi Salmeri; Carolina Dolci; Iacopo Tandoi; Massimo Candiani
Journal:  Int J Mol Sci       Date:  2022-04-17       Impact factor: 6.208

10.  Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.

Authors:  H S Kim; T H Kim; H H Chung; Y S Song
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.